Axsome Therapeutics, Inc. (AXSM): Price and Financial Metrics


Axsome Therapeutics, Inc. (AXSM)

Today's Latest Price: $73.96 USD

2.51 (3.51%)

Updated Dec 2 4:00pm

Add AXSM to Watchlist
Sign Up

Overall POWR Rating

Sign Up to See Ratings...FREE!

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 240 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

AXSM Stock Price Chart Interactive Chart >

Price chart for AXSM

AXSM Price/Volume Stats

Current price $73.96 52-week high $109.94
Prev. close $71.45 52-week low $35.44
Day low $69.38 Volume 469,640
Day high $74.28 Avg. volume 630,015
50-day MA $72.22 Dividend yield N/A
200-day MA $75.27 Market Cap 2.76B

Axsome Therapeutics, Inc. (AXSM) Company Bio

Axsome Therapeutics Inc. focuses on developing therapies for the management of pain, neurological disorders, and other central nervous system. The company was founded in 2012 and is based in New York City, New York.

Most Popular Stories View All

• Are Stocks Off to the Races in December?

• 3 Top Growth Stocks to Buy and Hold for Long Term

• Swerve to Avoid these 2 Electric Vehicle Stocks in December!

• 3 Top Airline Stocks to Buy for a Post Pandemic-World

• 4 Dividend-Paying Tech Stocks to Buy Before the New Year

View All Top Stories

AXSM Latest News Stream

Event/Time News Detail
Loading, please wait...
View All AXSM News

AXSM Latest Social Stream

Loading social stream, please wait...

View Full AXSM Social Stream

Latest AXSM News From Around the Web

Below are the latest news stories about Axsome Therapeutics Inc that investors may wish to consider to help them evaluate AXSM as an investment opportunity.

The Play On Axsome Therapeutics

Sometimes I wonder whether the world is being run by smart people who are putting us on or by imbeciles who really mean it."― Laurence J. Peter, The Peter Principle Today, we revisit Axsome Therapeutics (AXSM). This name was an original member of the Busted IPO Forum model portfolio and...

Bret Jensen on Seeking Alpha | October 2, 2020

BioXcel Therapeutics: Opportunity Emerges During Pandemic While Mental Health Is Being Ignored

Editor's note: Seeking Alpha is proud to welcome Chuchu Mei as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to SA Premium. Click here to find out more » BioXcel Therapeutics (BTAI) is...

Chuchu Mei on Seeking Alpha | September 23, 2020

Immunomedics, Scientific Games: 5 Top Gainers for Monday

Immunomedics, Scientific Games, Axsome Therapeutics, Seattle Genetics and Vaxart are some of the top gainers for Monday.

The Street | September 14, 2020

Earnings Scheduled For August 10, 2020

Companies Reporting Before The Bell • Acacia Research Inc. (NASDAQ: ACTG ) is expected to report quarterly loss at $0.02 per share on revenue of $200.00 thousand. • Akebia Therapeutics Inc. (NASDAQ: AKBA ) is expected to report quarterly loss at $0.50 per share on revenue of $74.18 million. • Apyx Medical Inc. (NASDAQ: APYX ) is estimated to report quarterly loss at $0.21 per share on revenue of $1.96 million. • Avadel Pharmaceuticals Inc. (NASDAQ: AVDL ) is estimated to report quarterly loss at $0.10 per share on revenue of $7.37 million. • Axsome Therapeutics Inc. (NASDAQ: AXSM ) is estimated to report earnings for its second quarter. • Liberty Braves Group Inc. (NASDAQ: BATRK ) is estimated to report earnings for its second quarter. • Biohaven Pharmaceutical Inc. (NYSE: BHVN ) is exp...

Benzinga | August 10, 2020

Axsome Therapeutics to Report Second Quarter 2020 Financial Results on August 10, 2020

Axsome to host conference call and webcast on Monday, August 10, 2020 at 8:00 AM Eastern TimeNEW YORK, July 30, 2020 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, today announced that it will report its financial results for the second quarter of 2020 on Monday, August 10, 2020 before the opening of the U.S. financial markets. Axsome’s management team will host a conference call at 8:00 AM Eastern Time on August 10, 2020 to discuss these results and provide a business update.To participate in the live conference call, please dial (844) 698-4029 (toll-free domestic) or (647) 253-8660 (international), and use the conference ID 4876676. A live webcast of the ...

Yahoo | July 30, 2020

Read More 'AXSM' Stories Here

AXSM Price Returns

1-mo 10.62%
3-mo 3.98%
6-mo -4.42%
1-year 62.16%
3-year 1,302.09%
5-year 760.00%
YTD -28.44%
2019 3,565.25%
2018 -49.64%
2017 -17.04%
2016 -27.18%
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7604 seconds.